U.S. Capital Markets Stock News

NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Rides MRNA Cancer Optimism On A Valuation That Still Looks Modest

Pfizer (PFE) moved back onto investor watchlists after Merck and Moderna reported positive Phase 3 results for an mRNA melanoma treatment, lifting sentiment toward companies with oncology focused mRNA pipelines. See our latest analysis for Pfizer. Across 2026, Pfizer’s share price has shifted from COVID reset concerns to renewed interest in its pipeline, with a 30 day share price return of 11.43% and a 1 year total shareholder return of 15.54%. Short term momentum is building, although the 3...
NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) Shares Moved, What Is Driving Attention Now?

Nu Holdings (NYSE:NU) is back in focus after Q2 2026 earnings, with record quarterly net income above US$1b, higher net interest income, and a customer base that has now passed 139 million across Latin America. See our latest analysis for Nu Holdings. Nu Holdings shares currently trade at US$14.21 and the stock has slipped 16.5% on a year to date share price return. However, the 90 day share price return of 11.6% and 3 year total shareholder return of roughly 2x suggest longer term momentum...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Stock Looks Pricey Even With A 45% Value Gap

W. R. Berkley stock has delivered a strong 133.5% total return over the past five years, yet the current valuation signals are mixed, with an intrinsic value estimate from the Excess Returns model pointing to a large discount while market multiples suggest the shares are not cheap. Over five years, W. R. Berkley has returned 133.5%, which puts recent short term share price softness into the context of a strong longer term run. The creation of Berkley Meridian can support expectations for...
NYSE:MC
NYSE:MCCapital Markets

Moelis Stock And 2 Financials Tied To Rising Bond Yields

Bond markets are back in the spotlight as long term Treasury yields press near recent highs, oil prices reflect the Iran conflict, and Big Tech taps investors to fund AI ambitions. Rising borrowing costs can reshape how corporate bond deals get done. That is why this is a useful moment to look at three U.S. investment banks and securities dealers that are closely exposed to these cross currents. The stocks highlighted below are just a starting sample. The full screen surfaced 32 more U.S...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Is Fastenal (FAST) Stock Stretched Or Still Reasonable Today?

Fastenal stock has delivered a strong 105.3% total return over the past 5 years, yet the current valuation checks suggest the shares lean expensive rather than offering clear value at recent levels around US$50.66. Fastenal's 105.3% return over 5 years highlights how well long term holders have been rewarded, which raises the bar for what the current price already assumes about the future. The company’s scale and recurring demand for industrial supplies can support expectations for steady...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata (INOD) Pushes Into Federal AI Work As Growth Narrative Tests Valuation

Innodata (INOD) reaffirmed its full year 2026 revenue guidance, targeting year-over-year growth of 40% or more, while also pushing deeper into U.S. federal AI contracts through expanded evaluation and assurance services. See our latest analysis for Innodata. At a share price of US$62.79, Innodata has seen momentum cool in recent months with a 90 day share price return that declined 34.24%, even as its 1 year total shareholder return of 63.18% and very large 5 year total shareholder return...
NYSE:ICE
NYSE:ICECapital Markets

Intercontinental Exchange (ICE) Hit Record Open Interest In Global Sugar Markets

Intercontinental Exchange (NYSE: ICE) reported record open interest in its global sugar markets, marking a new high for the derivatives platform. The record level reflects strong hedging demand from market participants responding to shifting sugar supply and demand fundamentals. Weather related uncertainties and imbalances in global sugar trade are driving increased use of ICE contracts for price discovery and risk management. For broader context on how exchanges and infrastructure...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Affirm Holdings (AFRM) Shares Dropped, So What Is Driving Attention Now?

Affirm Holdings (AFRM) has drawn fresh attention after recent share price moves, with the stock closing at US$75.05 on 19 August 2026. Investors are weighing this against its latest reported financial profile and multi-year return record. See our latest analysis for Affirm Holdings. For context, Affirm Holdings' recent pullback, with a 1-day share price return down 2.95% and a 7-day share price return down 4.21%, comes after a 90-day share price return of 15.07% and a very large 3-year total...
NasdaqGS:TCOM
NasdaqGS:TCOMHospitality

Does Softer EPS Outlook With Rising Sales Change The Bull Case For Trip.com Group (TCOM)?

Trip.com Group is preparing to report its June 2026-quarter results, with analysts expecting earnings to fall year over year even as revenue rises. Consensus earnings-per-share estimates have been revised lower over the past month, highlighting growing uncertainty about the company’s short-term profitability heading into this past earnings release. We’ll now explore how these tempered profit expectations ahead of earnings could influence Trip.com Group’s broader investment narrative. The...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

J&J Snack Foods (JJSF) Could Be 20% Undervalued As Dividend News Puts Valuation Back Focus

J&J Snack Foods (JJSF) drew investor attention after its board declared a quarterly cash dividend of $0.80 per share, payable on October 6, 2026, to shareholders of record on September 15, 2026. See our latest analysis for J&J Snack Foods. At a share price of $88.44, J&J Snack Foods has seen a 14.31% 1 month share price return and an 18.63% 3 month share price return, while its 1 year total shareholder return declined 20.91%. This suggests recent momentum contrasts with weaker longer term...
NYSE:AA
NYSE:AAMetals and Mining

How Investors May Respond To Alcoa (AA) Amid Tighter Global Aluminum Supply And Capital Discipline

Earlier in August 2026, Eagle Capital Management’s Q2 investor letter highlighted Alcoa’s favorable multi‑year aluminum supply‑demand backdrop and management’s disciplined capital allocation. The letter emphasized how China’s smelter capacity caps and higher-cost new supply elsewhere are supporting stronger pricing for aluminum and alumina, potentially enhancing Alcoa’s earnings power. Now, we’ll explore how this tighter global aluminum supply picture could reshape Alcoa’s previously...
NasdaqCM:WYFI
NasdaqCM:WYFIIT

3 Profitable AI Stocks Turning Real Demand Into Revenue

Global demand for AI related exports is still resilient, with Taiwan and Japan reporting strong orders for semiconductors and electrical machinery. That points to real-world AI spending flowing through supply chains rather than just into hype. For investors, the opportunity is in companies already turning AI investment into earnings. This article highlights three stocks from the Profitable AI Stocks screener that fit that profile. The three stocks below are just a starting sample, with the...
NYSE:ZIM
NYSE:ZIMShipping

ZIM (NYSE:ZIM) Stock Drifts Higher Even As Margin Quality Frays

ZIM Integrated Shipping Services slipped 0.9% today, a mild pullback for a stock that has drifted higher over the past month, even as the latest quarter puts the company’s margin story under a harsh spotlight. The headline is not the return to profit on US$1.78b of revenue. It is the squeeze behind that profit. Trailing net margin now sits at 2.2%, far below where it was a year ago, while the last twelve months still include a large one off gain of US$174.6m that flatters the earnings base...
NasdaqGS:CPB
NasdaqGS:CPBFood

Campbell's (CPB) Files A Shelf Registration, Is The Stock Cheap Or Pricey?

Campbell's (CPB) has filed an omnibus shelf registration covering capital stock, preferred stock, debt securities, warrants, purchase contracts and units. This broad filing gives the company flexibility for potential future financing. See our latest analysis for Campbell's. Campbell's share price has risen 6.45% over the past 30 days and 15.55% over 90 days, although the year to date share price return is down 14.18% and the 1 year total shareholder return is down 22.35%. As a result, recent...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?

In the past week, Interparfums received an upgrade to Zacks Rank #2 (Buy), reflecting higher analyst earnings estimates and a more favorable outlook for its profitability. This shift in analyst sentiment highlights how changes in earnings expectations can influence perceptions of Interparfums’ underlying business quality and prospects. Next, we’ll explore how this improved earnings outlook, as signaled by the Zacks upgrade, shapes Interparfums’ broader investment narrative. We've...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool (POOL) Pullback Keeps Undervalued Narrative In Focus

Pool (POOL) has come under pressure in recent trading, with the stock down roughly 3% over the past week and about 3% over the past month, compared with a modest gain over the past 3 months. See our latest analysis for Pool. The recent pullback extends a weaker run for Pool, with the share price down 17.14% year to date and the 1 year total shareholder return declining 36.78%. This points to fading momentum despite a modest 90 day share price gain of 3.08%. If Pool's recent moves have you...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Kaiser Aluminum (KALU) Stock Dropped, So What Is Driving Attention Now?

Leadership transition puts Kaiser Aluminum stock in focus Kaiser Aluminum (KALU) has drawn fresh attention after announcing that Fred Stephan will become Chief Executive Officer and President on November 1, 2026, and that current CEO Keith A. Harvey will move to the role of Executive Chairman. See our latest analysis for Kaiser Aluminum. Alongside the leadership news, Kaiser Aluminum’s share price has slipped recently, with a 7 day share price return down 17.24% and a 90 day share price...
NYSE:GPI
NYSE:GPISpecialty Retail

Board Expansion and Dividend Raise New Questions About Group 1 Automotive's Capital Priorities (GPI)

On August 10, 2026, Group 1 Automotive announced the appointment of former Ulta Beauty CEO David C. Kimbell to its expanded ten-member Board and Audit Committee, and its Board approved a US$0.55 per share cash dividend payable on September 15, 2026 to stockholders of record on September 1, 2026. Kimbell’s background in omnichannel retail, brand building and customer loyalty from Ulta Beauty and Best Buy brings consumer-focused expertise that could influence how Group 1 Automotive approaches...
NYSE:FIGS
NYSE:FIGSLuxury

FIGS (FIGS) Stock May Be Trading At A Premium As Growth Drives It

FIGS stock has delivered a strong 129.5% gain over the past three years, yet its low value score and an overvalued read on market multiples suggest the recent share price strength may be running ahead of what the current fundamentals justify. Over the past three years, FIGS has returned 129.5%, which puts added focus on whether today’s valuation leaves much margin for error. Future growth in demand for its healthcare apparel and the company’s ability to convert that into consistent cash flow...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections (WCN), What Is Behind The Fresh Attention?

Waste Connections (WCN) has launched a new share repurchase program that allows the company to buy back up to 12,578,462 common shares, representing 5% of its 251,569,244 issued and outstanding shares. See our latest analysis for Waste Connections. The share repurchase plan comes as Waste Connections trades at US$168.33, with the share price return rising 8.10% over the past 90 days while the 1 year total shareholder return has declined 8.96%. This suggests recent momentum has improved...
NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

Is Xencor (XNCR) Undervalued After Its Recent Share Price Surge?

Xencor (XNCR) has drawn investor attention after recent share price gains over the past month and past 3 months, prompting a closer look at how its antibody focused pipeline and financial profile line up. See our latest analysis for Xencor. At a latest share price of US$27.00, Xencor has seen strong momentum build, with a 30 day share price return of 32.03% and a 1 year total shareholder return of 262.90%. However, the 5 year total shareholder return of 15.62% shows a much more mixed longer...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

How Investors May Respond To Madrigal (MDGL) Adding J&J R&D Leader John C. Reed To Its Board

On August 12, 2026, Madrigal Pharmaceuticals announced it had appointed John C. Reed, M.D., Ph.D., Johnson & Johnson’s Executive Vice President of Innovative Medicine R&D, to its Board of Directors, adding deep experience across oncology, immunology, neuroscience and other high‑need therapeutic areas. By bringing in a director who has led R&D at Johnson & Johnson, Sanofi and Roche and authored more than 900 scientific publications, Madrigal is signaling a strong emphasis on scientific rigor...
NasdaqGS:WIX
NasdaqGS:WIXIT

How Wix’s New Symphony AI Agent Platform Could Reshape Wix.com’s (WIX) AI-Led Growth Story

Earlier this month, Wix.com Ltd. launched Symphony by Wix, a standalone AI agent platform that builds proactive, business-specific virtual teams to help individuals and small and medium-sized businesses manage and grow their operations across existing tools and workflows. By making Symphony platform-agnostic and available via tiered subscriptions, Wix is extending its AI capabilities beyond its own website ecosystem to potentially serve a much broader base of businesses. Now we’ll explore...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares

Wave Life Sciences (NasdaqGM:WVE) has voluntarily filed to deregister its Ordinary Shares with the SEC under the Securities Exchange Act of 1934. The move changes the company’s reporting obligations and alters how its shares are handled in public markets. Wave Life Sciences has framed the decision as a corporate action with implications for shareholders and the company’s public status. For investors tracking how smaller listed biotechs adjust their public market footprint, this kind of...